( in Million)
Particulars
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Audited / UnAudited
UnAudited
UnAudited
UnAudited
Audited
Net Sales
73.82
117.01
43.36
105.54
Total Expenditure
50.38
93.15
44.18
125.39
PBIDT (Excl OI)
23.44
23.86
-0.82
-19.85
Other Income
3
3.07
13.97
-7.13
Operating Profit
26.44
26.93
13.15
-26.98
Exceptional Items
-12.17
NA
NA
NA
PBDT
12.73
25.27
11.02
-28.03
Depreciation
1.3
1.33
1.29
1.13
Profit Before Tax
11.43
23.94
9.73
-29.16
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
5.79
21.05
6.32
-16.45
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
5.79
21.05
6.32
-16.45
Minority Interest
0.23
0.13
3.31
-0.42
Shares of Associates
0.42
0.2
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
6.03
21.61
9.64
-16.67
Equity Capital
158.85
158.85
158.85
158.85
Calculated EPS
0.18
0.68
0.30
-0.52
Calculated EPS (Annualised)
0.75
2.72
1.21
-2.09
No of Public Share Holdings
15011031
15021176
15021176
15021176
% of Public Share Holdings
47.25
47.28
47.28
47.28
PBIDTM% (Excl OI)
31.75
20.39
-1.89
-18.80
PBIDTM%
35.81
23.01
30.32
-25.56
PBDTM%
17.24
21.59
25.41
-26.55
PBTM%
15.48
20.45
22.44
-27.62
PATM%
7.85
17.98
14.57
-15.58